MarketCapExport financials
Viemed Healthcare (VMD)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Viemed Healthcare Balance Sheet 2025-2011 | VMD
Brief overview of Viemed Healthcare's financial position
Balance sheet changes are traced across five available annual reports between 2021 and 2025.
The asset base grew from $118 million to $199.2 million, or +68.8%. Average annual growth of roughly 14% was strong.
Liability growth of +140.4% exceeded asset growth of +68.8%, increasing reliance on outside funding.
The equity-to-assets ratio is 71.1%, compared with 80.4% five periods ago. The balance sheet has a substantial internal cushion.
Cash exceeds interest-bearing debt, producing net debt of -$1 million. The balance sheet therefore carries a net cash position.
Cash accounts for 6.8% of assets versus 24.1% initially. The change indicates the degree of financial flexibility.
Retained earnings stand at $102.9 million; the five-period change was +40.3%. This reflects accumulated business performance.
What the balance sheet shows
Taken together, the figures indicate acceptable resilience for Viemed Healthcare. The next assessment depends on debt and equity trends.
Annual Balance Sheet Viemed Healthcare
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-1.01 M | -13.1 M | -6.16 M | - | -22.6 M | -23.3 M | -3.98 M | -6.99 M | 81 K | 2.15 M | - | - | - | - | - |
Long Term Debt |
11.3 M | 3.59 M | 6 M | - | 4.31 M | 5.8 M | 7.63 M | - | - | - | - | - | - | - | - |
Long Term Debt Current |
1.2 M | 811 K | 678 K | 495 K | 1.48 M | 1.84 M | 1.75 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
14.6 M | 6.44 M | 8.88 M | 1.09 M | 5.33 M | 7.85 M | 13 M | 1.51 M | 798 K | 2.63 M | - | - | - | - | - |
Total Current Liabilities |
41.1 M | 37.3 M | 32.1 M | 18.9 M | 17.8 M | 23 M | 25.9 M | - | - | - | - | - | - | - | - |
Total Liabilities |
55.6 M | 43.8 M | 41 M | 19.9 M | 23.1 M | 30.9 M | 38.9 M | 18.5 M | 13.9 M | 11.8 M | - | - | - | - | - |
Deferred Revenue |
7.52 M | 6.69 M | 6.21 M | 4.62 M | 3.75 M | 3.41 M | 3.32 M | - | - | - | - | - | - | - | - |
Retained Earnings |
103 M | 89.7 M | 79.5 M | 69.8 M | 73.3 M | 65.6 M | 34.1 M | 29.6 M | 21 M | 12.8 M | - | - | - | - | - |
Total Assets |
199 M | 177 M | 155 M | 117 M | 118 M | 113 M | 82.6 M | 53.5 M | 37.7 M | 24.7 M | - | - | - | - | - |
Cash and Cash Equivalents |
13.5 M | 17.5 M | 12.8 M | 16.9 M | 28.4 M | 31 M | 13.4 M | 10.4 M | - | - | - | - | - | - | - |
Book Value |
144 M | 133 M | 114 M | 97.1 M | 94.8 M | 81.7 M | 43.7 M | 35 M | 23.7 M | 12.9 M | - | - | - | - | - |
Total Shareholders Equity |
142 M | 131 M | 114 M | 97.1 M | 94.8 M | 81.7 M | 43.7 M | 32.6 M | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet Viemed Healthcare
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.84 M | 3.09 M | 2.03 M | 2.36 M | 2.41 M | 1.7 M | 1.9 M | 2.01 M | 1.98 M | 2.1 M | 2.04 M | 2.18 M | 215 K | 143 K | - | 199 K | 4.16 M | 4.23 M | 4.27 M | 4.31 M | 4.35 M | 4.85 M | 5.32 M | 5.8 M | 6.26 M | 6.72 M | 7.18 M | 7.63 M | 8.08 M | 4.7 M | 7.63 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
8.32 M | 10.4 M | 10.9 M | 14.6 M | 22.7 M | 5.71 M | 5.84 M | 6.44 M | 6.29 M | 11.3 M | 8.48 M | 8.88 M | 9.03 M | 13 M | 1.17 M | 1.09 M | 4.95 M | 4.82 M | 5.23 M | 5.33 M | 5.91 M | 6.43 M | 7.72 M | 7.85 M | 8.42 M | 9.28 M | 11.9 M | 13 M | 13.1 M | 7.49 M | 13 M | 1.51 M | 1.51 M | 1.51 M | 1.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
55.6 M | 58.3 M | 51.6 M | 55.6 M | 66.9 M | 43 M | 41.3 M | 43.8 M | 42.7 M | 42.8 M | 38.6 M | 41 M | 40.6 M | 44.6 M | 24.6 M | 19.9 M | 25.5 M | 22.7 M | 23 M | 23.1 M | 26.1 M | 24.8 M | 29.6 M | 30.9 M | 38.8 M | 41 M | 38 M | 38.9 M | 39.7 M | 34.9 M | 38.9 M | 21.1 M | 18.5 M | 18.5 M | 15.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
8.02 M | 8 M | 7.48 M | 7.52 M | 7.81 M | 7.19 M | 6.8 M | 6.69 M | 6.82 M | 6.72 M | 6.09 M | 6.21 M | 6.22 M | 5.96 M | 4.7 M | 4.62 M | 4.64 M | 4.4 M | 3.89 M | 3.75 M | 3.8 M | 3.74 M | 3.42 M | 3.41 M | 3.61 M | 3.28 M | 3.39 M | 3.32 M | 3.36 M | 3.28 M | 3.32 M | 2.59 M | 2.48 M | 2.27 M | 2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
113 M | 108 M | 105 M | 103 M | 97.3 M | 93.8 M | 90.7 M | 89.7 M | 85.4 M | 81.6 M | 80.1 M | 79.5 M | 76 M | 73.2 M | 70.9 M | 69.8 M | 68.1 M | 68.9 M | 73.1 M | 73.3 M | 69.2 M | 67.5 M | 65.9 M | 65.6 M | 60.6 M | 57.8 M | 38.4 M | 34.1 M | 31.7 M | 28.9 M | 34.1 M | 27.1 M | 29.6 M | 29.6 M | 21.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
208 M | 204 M | 197 M | 199 M | 202 M | 185 M | 178 M | 177 M | 170 M | 164 M | 155 M | 155 M | 149 M | 149 M | 125 M | 117 M | 119 M | 116 M | 119 M | 118 M | 115 M | 111 M | 113 M | 113 M | 114 M | 112 M | 86.8 M | 82.6 M | 80 M | 71 M | 82.6 M | 53.7 M | 53.5 M | 53.5 M | 40.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
9.68 M | 10.7 M | 9.76 M | 13.5 M | 11.1 M | 20 M | 10.2 M | 17.5 M | 11.3 M | 8.81 M | 7.31 M | 12.8 M | 10.1 M | 10.2 M | 23.5 M | 16.9 M | 21.5 M | 21.9 M | 29.2 M | 28.4 M | 26.9 M | 31.2 M | 31.1 M | 31 M | 32.4 M | 29.7 M | 8.41 M | 13.4 M | 12.6 M | 7.69 M | 13.4 M | 10.4 M | 10.4 M | 10.4 M | 4.63 M | 5.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
152 M | 146 M | 146 M | 144 M | 135 M | 142 M | 137 M | 133 M | 127 M | 121 M | 116 M | 114 M | 109 M | 105 M | 100 M | 97.1 M | 93.9 M | 93.2 M | 96 M | 94.8 M | 89.4 M | 86.3 M | 83.4 M | 81.7 M | 75.2 M | 71.1 M | 48.8 M | 43.7 M | 40.3 M | 36.1 M | 43.7 M | 32.6 M | 35 M | 35 M | 24.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
152 M | 146 M | 146 M | 144 M | 135 M | 142 M | 137 M | 133 M | 127 M | 121 M | 116 M | 114 M | 109 M | 105 M | 100 M | 97.1 M | 93.9 M | 93.2 M | 96 M | 94.8 M | 89.4 M | 86.3 M | 83.4 M | 81.7 M | 75.2 M | 71.1 M | 48.8 M | 43.7 M | 40.3 M | 36.1 M | 43.7 M | 32.6 M | 35 M | 35 M | 24.7 M | 22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of Viemed Healthcare, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Israel
France
Canada
Britain
